Emanuela Palmerini

University of Toronto

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Radiology

40%

Epidemiology

20%

Oncology

60%

Solid Tumor

40%

Cancer Research

30%

Sarcoma Research

20%

Multiple Myeloma

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

Article Link

Year:

2023

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)

Article Link

Year:

2023

Reply to D.J. Benedetti et al

Article Link

Year:

2023

Outcome of rare primary malignant bone sarcoma (RPMBS) treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO‐B.O.S.S)

Article Link

Year:

2023

Reply to D.J. Benedetti et al

Article Link

Year:

2023

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Article Link

Year:

2022

Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib

Article Link

Year:

2022

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study

Article Link

Year:

2022

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis

Article Link

Year:

2022

High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling

Article Link

Year:

2022

Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools

Article Link

Year:

2021

Collaborators12

Vittorio Lorenzo Quagliuolo

Chief

IRCCS Humanitas Research Hospital

ITALY

Javier Martinez-Trufero

Associated Proffesor

Universidad de Murcia Facultad de Medicina

SPAIN

Sandro Pasquali

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Javier Martín-Broto

SPAIN

Nicholas M. Bernthal

UNITED STATES

Laura Pazzaglia

IRCCS Istituto Ortopedico Rizzoli

ITALY

John Healey

Chief of Orthopaedic Surgery

Memorial Sloan Kettering Cancer Center

UNITED STATES

Marco Gambarotti

IRCCS Istituto Ortopedico Rizzoli

ITALY

Antonella Brunello

Istituto Oncologico Veneto IOV-IRCCS

ITALY

Elisa Carretta

IRCCS Istituto Ortopedico Rizzoli

ITALY

Hans Gelderblom

Prof.dr.

Leiden University Medical Center

NETHERLANDS

Sebastian Bauer

Professor / Chair

Universität Duisburg-Essen

GERMANY

How do I reach out?

Meet Kite AI